These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20225093)

  • 1. p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions.
    de Biase D; Morandi L; Degli Esposti R; Ligorio C; Pession A; Foschini MP; Eusebi V
    Virchows Arch; 2010 Apr; 456(4):395-401. PubMed ID: 20225093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
    Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
    Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
    Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
    Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 expression in benign and malignant breast lesions.
    Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
    Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
    Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
    J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
    Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
    Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
    Alkhayyat R; Abbas A; Quinn CM; Rakha EA
    Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
    Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
    Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of p63 expression in squamous cell carcinoma of the oral cavity.
    Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Gatto MR; Frezza GP; Pession A
    Virchows Arch; 2004 Apr; 444(4):332-9. PubMed ID: 14997391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
    Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
    Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
    Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
    Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcription-polymerase chain reaction and western blotting analysis for detection of p63 isoforms in uterine cervical cancers.
    Lin Z; Nan Y; Zhang X; Zhao Y; Kim C; Kim I
    Int J Gynecol Cancer; 2006; 16(4):1643-7. PubMed ID: 16884378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
    Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
    BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
    Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
    Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.